Carnegie Capital Asset Management, LLC Eli Lilly & CO Transaction History

Carnegie Capital Asset Management, LLC

$3.34 Billion
Q3 2024

A detailed history of Carnegie Capital Asset Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Carnegie Capital Asset Management, LLC holds 7,268 shares of LLY stock, worth $5.44 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

7,268

Previous 6,812 6.69%

Holding current value

$5.44 Million

Previous $6.17 Million 4.41%

% of portfolio

0.19%

Previous 0.19%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$772.14 - $960.02 $352,095 - $437,769	456 Added 6.69%	7,268 $6.44 Million
Q2 2024 Jul 19, 2024	BUY	$724.87 - $909.04 $76,111 - $95,449	105 Added 1.57%	6,812 $6.17 Million
Q1 2024 May 03, 2024	BUY	$592.2 - $792.28 $10,067 - $13,468	17 Added 0.25%	6,707 $5.22 Million
Q4 2023 Jan 29, 2024	BUY	$525.19 - $619.13 $7,877 - $9,286	15 Added 0.22%	6,690 $3.9 Million
Q3 2023 Oct 10, 2023	SELL	$434.7 - $599.3 $134,322 - $185,183	-309 Reduced 4.42%	6,675 $3.59 Million
Q2 2023 Aug 04, 2023	BUY	$350.74 - $468.98 $419,835 - $561,369	1,197 Added 20.68%	6,984 $3.28 Million
Q1 2023 Apr 19, 2023	BUY	$310.63 - $364.82 $931 - $1,094	3 Added 0.05%	5,787 $1.99 Million
Q4 2022 Jan 23, 2023	BUY	$321.55 - $374.67 $65,917 - $76,807	205 Added 3.67%	5,784 $0
Q3 2022 Oct 13, 2022	SELL	$296.48 - $337.87 $528,327 - $602,084	-1,782 Reduced 24.21%	5,579 $1.8 Million
Q2 2022 Aug 02, 2022	BUY	$278.73 - $327.27 $307,996 - $361,633	1,105 Added 17.66%	7,361 $2.39 Million
Q2 2022 Jul 13, 2022	SELL	$278.73 - $327.27 $408,060 - $479,123	-1,464 Reduced 18.96%	6,256 $1.44 Million
Q1 2022 Apr 11, 2022	SELL	$234.69 - $291.66 $91,059 - $113,164	-388 Reduced 4.79%	7,720 $2.21 Million
Q4 2021 Jan 21, 2022	BUY	$224.85 - $279.04 $431,712 - $535,756	1,920 Added 31.03%	8,108 $2.24 Million
Q3 2021 Oct 08, 2021	SELL	$221.6 - $272.71 $15,068 - $18,544	-68 Reduced 1.09%	6,188 $1.43 Million
Q2 2021 Jul 16, 2021	BUY	$180.55 - $233.54 $46,040 - $59,552	255 Added 4.25%	6,256 $1.44 Million
Q1 2021 Apr 12, 2021	BUY	$164.32 - $212.72 $83,310 - $107,849	507 Added 9.23%	6,001 $1.12 Million
Q4 2020 Feb 08, 2021	BUY	$130.46 - $172.63 $521 - $690	4 Added 0.07%	5,494 $928,000
Q3 2020 Oct 13, 2020	SELL	$146.22 - $169.13 $877 - $1,014	-6 Reduced 0.11%	5,490 $813,000
Q2 2020 Jul 09, 2020	SELL	$136.42 - $164.18 $103,542 - $124,612	-759 Reduced 12.13%	5,496 $902,000
Q1 2020 May 08, 2020	SELL	$119.05 - $147.35 $15,595 - $19,302	-131 Reduced 2.05%	6,255 $868,000
Q4 2019 Feb 13, 2020	BUY	$106.92 - $132.43 $123,813 - $153,353	1,158 Added 22.15%	6,386 $839,000
Q3 2019 Nov 20, 2019	BUY	$106.79 - $116.16 $10,358 - $11,267	97 Added 1.89%	5,228 $585,000
Q2 2019 Jul 24, 2019	SELL	$110.79 - $129.32 $56,281 - $65,694	-508 Reduced 9.01%	5,131 $568,000
Q1 2019 May 14, 2019	BUY	$111.31 - $131.02 $44,857 - $52,801	403 Added 7.7%	5,639 $732,000
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $289,212 - $324,005	-2,731 Reduced 34.28%	5,236 $606,000
Q3 2018 Nov 27, 2018	BUY	$85.86 - $107.31 $244,014 - $304,975	2,842 Added 55.45%	7,967 $907,000
Q2 2018 Aug 16, 2018	BUY	$75.7 - $86.88 $302 - $347	4 Added 0.08%	5,125 $525,000
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $20,407 - $24,090	-275 Reduced 5.1%	5,121 $422,000
Q4 2017 Feb 12, 2018	BUY	$81.94 - $87.89 $37,610 - $40,341	459 Added 9.3%	5,396 $414,000
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $5,086 - $5,645	66 Added 1.35%	4,937 $430,000
Q2 2017 Aug 14, 2017	BUY	N/A	4,871	4,871 $399,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Carnegie Capital Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carnegie Capital Asset Management, LLC with notifications on news.

Account

Carnegie Capital Asset Management, LLC Eli Lilly & CO Transaction History